Inventor
REYNOLDS JOSEPH G
US3 patents
Patents
3 patentsUS9226966B2Jan 5, 2016
Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
MERRIMACK PHARMACEUTICALS INC2 citations54
US9913901B2Mar 13, 2018
Combination therapy for treating HER2-positive cancers
MERRIMACK PHARMACEUTICALS INC0 citations45
US9610249B2Apr 4, 2017
Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
MERRIMACK PHARMACEUTICALS INC0 citations44